TriSalus Life Sciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
29.26 |
44.84 |
69.44 |
101.14 |
125.74 |
148.32 |
| Przychód Δ r/r |
0.00% |
53.23% |
54.87% |
45.65% |
24.32% |
17.96% |
| Przychód (min) |
29.22 |
43.78 |
61.60 |
94.73 |
117.77 |
138.92 |
| Przychód (max) |
29.29 |
45.55 |
84.56 |
113.42 |
141.00 |
166.31 |
| EBITDA (średnia) |
-29.26 |
-44.84 |
-69.44 |
-101.14 |
-125.74 |
-148.32 |
| EBIT (średnia) |
-29.26 |
-44.84 |
-69.44 |
-101.14 |
-125.74 |
-148.32 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-33.60 |
-21.61 |
-6.69 |
8.41 |
15.81 |
32.20 |
| Zysk netto % |
-114.80% |
-48.19% |
-9.63% |
8.32% |
12.58% |
21.71% |
| EPS (średnia) |
-1.26 |
-0.82 |
-0.17 |
0.27 |
0.60 |
1.22 |
| Liczba analityków (Przychody) |
4 |
5 |
8 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
4 |
3 |
5 |
3 |
1 |
1 |
| symbol |
TLSI |
TLSI |
TLSI |
TLSI |
TLSI |
TLSI |